Sharing ideas that do good

New drug for treating melanoma and other cancers

post-image
Researchers at the University of Colorado Cancer Centre have published their work on NLRP3 - an intracellular complex found to participate in melanoma-mediated inflammation leading to tumour growth and progression. The researchers found that by inhibiting this complex, they can reduce inflammation and tumour growth. The studies have so far used an oral NLRP3 inhibitor (Dapansutrile) which has shown to be effective in treating gout and heart disease. It is currently being tested in COVID-19.  | https://medicalxpress.com/news/2021-04-drug-tumors.html?utm_source=nwletter&utm_medium=email&utm_campaign=daily-nwletter
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Mel Raassina

9 April 2021

 
6 Like


Related Posts

Healthcare

post-image

Wireless - Brain Computer Interface
16 April 2021 by Jenny Morawsk... 0 Comments
 
3 Like

Healthcare

post-image

QLD company receives accreditation for 15-minute COVID-19 rapid test in Europe
16 April 2021 by Mel Raassina 0 Comments
 
1 Like

Healthcare

post-image

Mining the gut microbiome for Parkinson's
30 March 2021 by Mel Raassina 0 Comments
 
7 Like